EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Efficacy of low-intensity pulsed ultrasound in the treatment of COVID-19 pneumonia

Wen Li, Xiao Li, Zhibin Kong, Bin Chen, Hongsheng Zhou, Yimin Jiang, Weimei Li, Lichang Zhong, Xinyu Zhang, Kaihua Zhang, Lili Zhang, Xiangyun Zong und 2 weitere

Ultraschall in der Medizin - European Journal of Ultrasound · 01.12.2023 · 44 (06) · e274-e283

DOI: 10.1055/a-2133-0835 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Ultraschall in der Medizin - European Journal of Ultrasound, erschienen am 01.12.2023. Verfasst von Wen Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shanghai Science and Technology Commission, National Key R&D Program, Shanghai Sixth People's Hospital COVID-19 Pneumonia Epidemic Emergency Special Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

As a public health emergency of international concern, coronavirus disease 2019 (COVID-19) still lacks specific antiviral drugs, and symptomatic treatment is currently the mainstay. The overactivated inflammatory response in COVID-19 patients is associated with a high risk of critical illness or even death. Low-intensity pulsed ultrasound (LIPUS) can mitigate inflammation and inhibit edema formation. We aimed to investigate the efficacy of LIPUS therapy for COVID-19 pneumonia. Materials and Methods 62 patients were randomly assigned to a treatment group (LIPUS treatment area – Group 1; self-control area – Group 2) and an external control group (Group 3). The primary outcomes were the volume absorption rate (VAR) and the area absorption rate (AAR) of lung inflammation in CT images.

Results

After an average duration of treatment 7.2 days, there were significant differences in AAR and VAR between Group 1 and Group 2 (AAR 0.25 vs 0.12, p=0.013; VAR 0.35 vs 0.11, p=0.005), and between Group 1 and Group 3 (AAR 0.25 vs 0.11, p=0.047; VAR 0.35 vs 0.19, p=0.042). Neither AAR nor VAR was statistically different between Group 2 and Group 3. After treatment, C-reactive protein, interleukin-6, leukocyte, and fingertip arterial oxygen saturation (SaO2) improved in Group 1, while in Group 3 only fingertip SaO2 increased.

Conclusion

LIPUS therapy reduced lung inflammation and serum inflammatory factor levels in hospitalized COVID-19 patients, which might be a major advancement in COVID-19 pneumonia therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansUltrasonic Waves

Autor:innen und Institutionen

  • Department of Ultrasound, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Ultrasound, Institute of Ultrasound in Medicine and Engineering, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Respiratory Medicine, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Cardiovascular Medicine, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Shanghai Acoustics Jiao Tong University, Shanghai, China.
  • Department of Radiology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

ORCID-Profile: Wenkun Bai

Förderung

  • Shanghai Science and Technology Commission
  • National Key R&D Program
  • Shanghai Sixth People's Hospital COVID-19 Pneumonia Epidemic Emergency Special Project
  • Shanghai Sixth People's Hospital Surface Cultivation Project

Zitieren

APA

Li, W., Li, X., Kong, Z., Chen, B., Zhou, H., Jiang, Y., Li, W., Zhong, L., Zhang, X., Zhang, K., Zhang, L., Zong, X., Bai, W., & Zheng, Y. (2023). Efficacy of low-intensity pulsed ultrasound in the treatment of COVID-19 pneumonia. Ultraschall in der Medizin - European Journal of Ultrasound, 44(06), e274-e283. https://doi.org/10.1055/a-2133-0835

Vancouver

Li W, Li X, Kong Z, Chen B, Zhou H, Jiang Y, et al. Efficacy of low-intensity pulsed ultrasound in the treatment of COVID-19 pneumonia. Ultraschall in der Medizin - European Journal of Ultrasound. 2023;44(06):e274-e283. doi:10.1055/a-2133-0835

BibTeX
@article{Li2023,
  author = {Li, Wen and Li, Xiao and Kong, Zhibin and Chen, Bin and Zhou, Hongsheng and Jiang, Yimin and Li, Weimei and Zhong, Lichang and Zhang, Xinyu and Zhang, Kaihua and Zhang, Lili and Zong, Xiangyun and Bai, Wenkun and Zheng, Yuanyi},
  title = {Efficacy of low-intensity pulsed ultrasound in the treatment of COVID-19 pneumonia},
  journal = {Ultraschall in der Medizin - European Journal of Ultrasound},
  year = {2023},
  volume = {44},
  number = {06},
  pages = {e274--e283},
  doi = {10.1055/a-2133-0835}
}
Kostenlos starten →